Hsbc Holdings PLC Sells 142,534 Shares of Encompass Health Corporation $EHC

Hsbc Holdings PLC decreased its holdings in Encompass Health Corporation (NYSE:EHC - Free Report) by 37.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 237,052 shares of the company's stock after selling 142,534 shares during the period. Hsbc Holdings PLC owned 0.24% of Encompass Health worth $23,861,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in EHC. EP Wealth Advisors LLC boosted its stake in Encompass Health by 2.4% during the second quarter. EP Wealth Advisors LLC now owns 3,694 shares of the company's stock worth $453,000 after buying an additional 88 shares during the period. Gamco Investors INC. ET AL grew its stake in shares of Encompass Health by 2.0% during the first quarter. Gamco Investors INC. ET AL now owns 4,813 shares of the company's stock valued at $466,000 after buying an additional 94 shares during the last quarter. Gibson Capital LLC raised its holdings in shares of Encompass Health by 4.3% in the first quarter. Gibson Capital LLC now owns 2,431 shares of the company's stock worth $235,000 after buying an additional 101 shares during the period. Leuthold Group LLC boosted its holdings in Encompass Health by 0.3% during the 4th quarter. Leuthold Group LLC now owns 31,168 shares of the company's stock valued at $3,308,000 after acquiring an additional 104 shares during the period. Finally, Covestor Ltd increased its stake in Encompass Health by 24.4% in the fourth quarter. Covestor Ltd now owns 540 shares of the company's stock worth $57,000 after purchasing an additional 106 shares during the period. 97.25% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, CEO Mark Tarr sold 173,148 shares of the firm's stock in a transaction on Monday, August 10th. The stock was sold at an average price of $125.47, for a total value of $21,724,879.56. Following the completion of the transaction, the chief executive officer owned 267,814 shares in the company, valued at $33,602,622.58. This trade represents a 39.27% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP John Darby sold 4,858 shares of the stock in a transaction dated Monday, August 31st. The shares were sold at an average price of $121.09, for a total value of $588,255.22. Following the completion of the transaction, the executive vice president directly owned 75,041 shares in the company, valued at $9,086,714.69. This represents a 6.08% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 186,912 shares of company stock worth $23,434,845 over the last three months. Corporate insiders own 1.80% of the company's stock.

Encompass Health Stock Down 1.1%

Shares of EHC stock opened at $120.46 on Wednesday. The stock's fifty day moving average price is $116.14 and its 200 day moving average price is $107.73. Encompass Health Corporation has a 1-year low of $92.77 and a 1-year high of $127.99. The company has a market cap of $11.88 billion, a price-to-earnings ratio of 19.62, a price-to-earnings-growth ratio of 2.47 and a beta of 0.75. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.19 and a quick ratio of 1.19.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $1.55 earnings per share for the quarter, topping the consensus estimate of $1.48 by $0.07. The business had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.57 billion. Encompass Health had a return on equity of 18.08% and a net margin of 10.01%.The company's quarterly revenue was up 9.6% on a year-over-year basis. During the same quarter last year, the company earned $1.40 earnings per share. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. On average, research analysts expect that Encompass Health Corporation will post 6.08 earnings per share for the current fiscal year.

Encompass Health Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be paid a dividend of $0.21 per share. The ex-dividend date is Thursday, October 1st. This is an increase from Encompass Health's previous quarterly dividend of $0.19. This represents a $0.84 annualized dividend and a dividend yield of 0.7%. Encompass Health's payout ratio is presently 13.68%.

Analysts Set New Price Targets

A number of research analysts have recently commented on the stock. Leerink Partners set a $152.00 price target on shares of Encompass Health in a report on Friday, May 22nd. UBS Group boosted their price objective on shares of Encompass Health from $150.00 to $155.00 and gave the company a "buy" rating in a research report on Friday, August 7th. Weiss Ratings upgraded shares of Encompass Health from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Wednesday, August 12th. Wall Street Zen downgraded shares of Encompass Health from a "buy" rating to a "hold" rating in a research note on Saturday. Finally, Barclays increased their price objective on Encompass Health from $140.00 to $144.00 and gave the stock an "overweight" rating in a research note on Thursday, August 6th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Buy" and a consensus target price of $148.71.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.